10 results
Pulmonary and Non-Pulmonary Causes of ARDS #Diagnosis #EM #PCC #ARDS #Differential #Algorithm #Pulmonary #NonPulmonary #Causes #Ddxof
Pulmonary and Non-Pulmonary ... ARDS #Diagnosis #EM ... #PCC #ARDS #Differential ... #Algorithm #Pulmonary ... NonPulmonary #Causes #Ddxof
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
Pulmonary Embolism ... mortality #Diagnosis #Management ... #EM #IM #PCC #PESI ... #sPESI #risk #score ... #PE #PulmonaryEmbolism
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... Embolism #Diagnosis ... #EM #IM #PCC #PulmonaryEmbolism ... #Pulmonary #Embolism ... #Ddxof
Chest Pain Diagnosis and Management Algorithm
STEMI:
 - Hx: Pressure like CP, Radiation to arm/jaw, CAD risk
Algorithm STEMI ... Limb ischemia Pulmonary ... Embolism: - Hx ... pleuritic CP, Dyspnea, PE ... COPD, asthma, CF, PCP
Pediatric Fever Without a Source - 3 months to 3 years - Additional Workup Beyond Urine
Conjugate Vaccines (PCV ... ) #Diagnosis #Management ... #Peds #EM #Workup ... #Algorithm #PCV ... PneumococcalConjugateVaccines #NoUTI #ALiEM
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... vein thrombosis; PE ... = pulmonary embolism ... Anticoagulation #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... algorithm to determine ... Recent PCI/stenting ... since elective PCI ... medical and surgical management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Attempt if high risk ... Imaging: CXR- pulmonary ... Infection (sepsis), PE ... fluid overload, PCC ... APML #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... cancer • Septic emboli ... staining, NAA (PCR ... Inhibitor: • Risk ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... cancer • Septic emboli ... staining, NAA (PCR ... Inhibitor: • Risk ... TB #Diagnosis #Management